[PTGX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 11.32%
YoY- -13.08%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 4,167 254,953 60,000 0 0 0 0 -
PBT -31,292 210,666 27,335 -34,105 -38,460 -33,725 -34,194 -5.74%
Tax -676 3,326 -4,242 -827 -3,913 -2,296 -2,909 -62.23%
NP -30,616 207,340 27,335 -34,105 -38,460 -31,429 -31,285 -1.43%
Tax Rate - -1.58% 15.52% - - - - -
Total Cost 34,783 47,613 32,665 34,105 38,460 31,429 31,285 7.32%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -734.73 81.32 45.56 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.50 3.41 0.45 -0.58 -0.68 -0.62 -0.64 -15.18%
EPS Diluted -0.50 3.26 0.44 -0.58 -0.68 -0.62 -0.64 -15.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.